National Notifiable Diseases Surveillance System tables

A summary of diseases currently being reported by each jurisdiction.

Page last updated: 03 October 2013

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 53,347 notifications to the National Notifiable Diseases Surveillance System (NNDSS) with a notification received date between 1 January and 31 March 2013 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Top of page

Table 1: Reporting of notifiable diseases by jurisdiction

Disease

Data received from:

Bloodborne diseases

Hepatitis (NEC)

All jurisdictions

Hepatitis B (newly acquired)

All jurisdictions

Hepatitis B (unspecified)

All jurisdictions

Hepatitis C (newly acquired)

All jurisdictions except Queensland

Hepatitis C (unspecified)

All jurisdictions

Hepatitis D

All jurisdictions

Gastrointestinal diseases

Botulism

All jurisdictions

Campylobacteriosis

All jurisdictions except New South Wales

Cryptosporidiosis

All jurisdictions

Haemolytic uraemic syndrome

All jurisdictions

Hepatitis A

All jurisdictions

Hepatitis E

All jurisdictions

Listeriosis

All jurisdictions

STEC, VTEC*

All jurisdictions

Salmonellosis

All jurisdictions

Shigellosis

All jurisdictions

Typhoid

All jurisdictions

Quarantinable diseases

Cholera

All jurisdictions

Highly pathogenic avian influenza in humans

All jurisdictions

Plague

All jurisdictions

Rabies

All jurisdictions

Severe acute respiratory syndrome

All jurisdictions

Smallpox

All jurisdictions

Viral haemorrhagic fever

All jurisdictions

Yellow fever

All jurisdictions

Sexually transmissible infections

Chlamydial infection

All jurisdictions

Donovanosis

All jurisdictions

Gonococcal infection

All jurisdictions

Syphilis - congenital

All jurisdictions

Syphilis <2 years duration

All jurisdictions

Syphilis >2 years or unspecified duration

All jurisdictions

Vaccine preventable diseases

Diphtheria

All jurisdictions

Haemophilus influenzae type b

All jurisdictions

Influenza (laboratory confirmed)

All jurisdictions

Measles

All jurisdictions

Mumps

All jurisdictions

Pertussis

All jurisdictions

Pneumococcal disease (invasive)

All jurisdictions

Poliomyelitis

All jurisdictions

Rubella

All jurisdictions

Rubella - congenital

All jurisdictions

Tetanus

All jurisdictions

Varicella zoster (chickenpox)

All jurisdictions except New South Wales

Varicella zoster (shingles)

All jurisdictions except New South Wales

Varicella zoster (unspecified)

All jurisdictions except New South Wales

Vectorborne diseases

Arbovirus infection (NEC)

All jurisdictions

Barmah Forest virus infection

All jurisdictions

Dengue virus infection

All jurisdictions

Japanese encephalitis virus infection

All jurisdictions

Kunjin virus infection

All jurisdictions

Malaria

All jurisdictions

Murray Valley encephalitis virus infection

All jurisdictions

Ross River virus infection

All jurisdictions

Zoonoses

Anthrax

All jurisdictions

Australian bat lyssavirus

All jurisdictions

Brucellosis

All jurisdictions

Leptospirosis

All jurisdictions

Lyssavirus (NEC)

All jurisdictions

Ornithosis

All jurisdictions

Q fever

All jurisdictions

Tularaemia

All jurisdictions

Other bacterial infections

Legionellosis

All jurisdictions

Leprosy

All jurisdictions

Meningococcal infection

All jurisdictions

Tuberculosis

All jurisdictions

* Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (STEC/VTEC).
NEC Not elsewhere classified.

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 January to 31 March 2013, by date of diagnosis*

State or territory

Total 1st quarter 2013

Total 4th quarter 2012

Total 1st quarter 2012

Last 5 years mean 1st quarter

Ratio

Year to date 2013

Last 5 years YTD mean

Disease

ACT

NSW

NT

Qld

SA

Tas

Vic

WA

Bloodborne diseases

Hepatitis (NEC)

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Hepatitis B (newly acquired)

1

10

0

12

3

2

9

11

48

53

53

57.4

0.8

48

57.4

Hepatitis B (unspecified)

29

564

52

209

79

12

492

201

1,638

1,523

1,630

1,683.8

1.0

1,638

1,683.8

Hepatitis C (newly acquired)

6

13

1

NN

22

5

34

30

111

106

123

101.8

1.1

111

101.8

Hepatitis C (unspecified)

33

808

57

612

93

48

512

288

2,451

2,368

2,541

2,656.0

0.9

2,451

2,656.0

Hepatitis D

0

1

1

4

2

0

4

0

12

7

8

9.2

1.3

12

9.2

Gastrointestinal diseases

Botulism

0

1

0

0

0

0

1

0

2

0

0

0.2

10.0

2

0.2

Campylobacteriosis

105

NN

47

918

386

199

1,399

417

3,471

3,814

4,814

4,540.0

0.8

3,471

4,540.0

Cryptosporidiosis

19

590

26

286

37

42

575

143

1,718

432

1,453

1,246.2

1.4

1,718

1,246.2

Haemolytic uraemic syndrome

0

3

0

1

0

0

0

0

4

4

7

5.2

0.8

4

5.2

Hepatitis A

1

30

0

7

6

0

18

5

67

44

44

68.8

1.0

67

68.8

Hepatitis E

0

7

0

0

0

0

4

3

14

6

15

14.4

1.0

14

14.4

Listeriosis

1

11

1

6

0

1

6

3

29

27

27

27.4

1.1

29

27.4

STEC, VTEC §

1

10

0

7

22

0

4

0

44

32

36

32.4

1.4

44

32.4

Salmonellosis

72

1,131

119

1,092

252

113

1,009

362

4,150

2,761

3,961

3,802.2

1.1

4,150

3,802.2

Shigellosis

4

39

28

23

6

1

24

18

143

129

191

193.4

0.7

143

193.4

Typhoid Fever

1

23

0

12

5

0

24

3

68

31

56

43.2

1.6

68

43.2

Quarantinable diseases

Cholera

0

0

0

0

0

0

0

0

0

0

0

0.8

0.0

0

0.8

Highly Pathogenic Avian Influenza in Humans

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Plague

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Rabies

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Severe Acute Respiratory Syndrome

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Smallpox

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Viral haemorrhagic fever

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Yellow fever

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Sexually transmissible infections

Chlamydial infection ||¶

324

5,345

647

4,807

1,370

411

4,992

2,981

20,877

19,277

22,536

18,491.8

1.1

20,877

18,491.8

Donovanosis

0

0

0

0

0

0

0

0

0

0

0

0.2

0.0

0

0.2

Gonococcal infection ||

39

1,101

435

702

117

12

788

528

3,722

3,381

3,610

2,648.0

1.4

3,722

2,648.0

Syphilis – congenital

0

0

0

1

0

0

0

0

1

0

0

1.2

0.8

1

1.2

Syphilis < 2 years ||

4

163

4

76

8

6

99

26

386

344

350

350.0

1.1

386

350.0

Syphilis > 2 years or unspecified duration ‡||

2

77

15

83

31

5

183

35

431

296

332

333.8

1.3

431

333.8

Vaccine preventable diseases

Diphtheria

0

0

0

0

1

0

0

0

1

0

0

0.0

0.0

1

0.0

Haemophilus influenzae type b

0

2

0

1

0

0

0

0

3

3

3

4.4

0.7

3

4.4

Influenza (laboratory confirmed)

44

397

132

795

318

8

326

289

2,309

2,902

1,274

1,062.4

2.2

2,309

1,062.4

Measles

0

1

0

1

2

0

3

3

10

29

10

42.8

0.2

10

42.8

Mumps

0

23

0

8

1

2

9

28

71

40

40

59.2

1.2

71

59.2

Pertussis

48

635

38

1,217

156

323

776

399

3,592

5,800

7,240

6,726.2

0.5

3,592

6,726.2

Pneumococcal disease (invasive)

2

65

15

38

16

6

51

21

214

345

235

216.4

1.0

214

216.4

Poliomyelitis

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Rubella

0

1

0

0

0

0

0

0

1

5

13

12.8

0.1

1

12.8

Rubella Congenital

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Tetanus

0

1

0

0

1

0

0

1

3

4

1

1.8

1.7

3

1.8

Varicella zoster (Chickenpox)

7

NN

39

48

90

2

134

49

369

490

402

351.2

1.1

369

351.2

Varicella zoster (Shingles)

5

NN

44

13

463

70

288

296

1,179

1,131

1,085

836.0

1.4

1,179

836.0

Varicella zoster (Unspecified)

31

NN

1

1,187

36

20

668

313

2,256

2,269

2,078

1,660.0

1.4

2,256

1,660.0

Vectorborne diseases

Arbovirus infection (NEC)

0

0

1

4

0

0

0

0

5

1

3

3.8

1.3

5

3.8

Barmah Forest virus infection

3

133

130

661

33

0

25

443

1,428

642

454

624.8

2.3

1,428

624.8

Dengue virus infection

3

59

18

165

17

3

96

122

483

218

696

477.4

1.0

483

477.4

Japanese encephalitis virus infection

0

0

0

0

0

0

0

0

0

0

1

0.2

0.0

0

0.2

Kunjin virus infection

0

0

0

0

0

0

0

0

0

0

0

0.6

0.0

0

0.6

Malaria

8

24

7

44

2

2

21

29

137

95

76

108.0

1.3

137

108.0

Murray Valley encephalitis virus infection

0

0

0

0

0

0

0

0

0

0

1

2.4

0.0

0

2.4

Ross River virus infection

1

115

70

495

51

4

57

546

1,339

688

2,298

2,272.8

0.6

1,339

2,272.8

Zoonoses

Anthrax

0

0

0

0

0

0

0

0

0

0

0

0.2

0.0

0

0.2

Australian bat lyssavirus

0

0

0

1

0

0

0

0

1

0

0

0.0

0.0

1

0.0

Brucellosis

0

0

0

5

0

0

0

0

5

6

7

7.8

0.6

5

7.8

Leptospirosis

0

2

0

12

0

0

0

0

14

10

48

60.6

0.2

14

60.6

Lyssavirus (NEC)

0

0

0

0

0

0

0

0

0

0

0

0.0

0.0

0

0.0

Ornithosis

0

1

0

0

0

0

3

3

7

31

12

17.0

0.4

7

17.0

Q fever

0

28

0

47

7

0

9

2

93

81

108

95.2

1.0

93

95.2

Tularaemia

0

0

0

0

0

0

0

0

0

0

0

0.5

0.0

0

0.5

Other bacterial infections

legionellosis

0

20

0

20

14

2

23

16

95

98

95

73.6

1.3

95

73.6

Leprosy

0

1

00

0

0

0

1

0

2

2

0

1.4

1.4

2

1.4

Meningoxoxxal disease (invasive)**

1

8

0

10

6

1

7

6

39

39

34

44.8

0.9

39

44.8

Tuberculosis

5

86

13

53

19

2

93

33

304

382

322

302.0

1.0

304

302.0

Total

800

11,529

1,941

13,683

3,672

1,302

12,767

7,653

53,347

49,946

58,323

53,347

* Date of diagnosis is the date of symptom onset, or if this is not available, the earliest of the specimen collection date, the notification date (when the health professional signed the form or laboratory issued the results) or the notification receive date (when notification of the disease was received by the health authority). Hepatitis B and C and tuberculosis were analysed by date of notification.
† Rate per 100,000 population. The annualisation factor was 4.0.
‡ Newly-acquired hepatitis and syphilis includes cases where the infection was determined to have been acquired within 24 months prior to diagnosis.
§ Unspecified hepatitis includes cases where the duration of infection could not be determined.
|| Infections with Shiga-like toxin (verotoxin) producing Escherichia coli.
¶ In the national case definitions for chlamydial, gonnoccocal and syphilis infection, the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode.
** Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia, where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular specimens are excluded, and Western Australia also excludes perinatal infection.
†† Only invasive meningococcal disease is nationally notifiable, but New South Wales, the Australia Capital Territory and South Australia also report conjunctival cases.
NN Not notifiable
NEC Not elsewhere classified

Top of page

Table 3: Notification rates of diseases, 1 January to 31 March 2013, by state or territory. (Annualised rate per 100,000 population)*†

Disease

State or territory

Aust

ACT

NSW

NT

Qld

SA

Tas

Vic

WA

Bloodborne diseases

Hepatitis (NEC)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Hepatitis B (newly acquired)

1.1

0.6

0.0

1.1

0.7

1.6

0.7

1.9

0.9

Hepatitis B (unspecified) §

32.5

31.7

92.5

18.7

19.6

9.6

35.9

35.1

29.7

Hepatitis C (newly acquired)

6.7

0.7

1.8

NN

5.4

4.0

2.5

5.2

2.5

Hepatitis C (unspecified) §

37.0

45.4

101.4

54.8

23.0

38.5

37.3

50.3

44.4

Hepatitis D

0.0

0.1

1.8

0.4

0.5

0.0

0.3

0.0

0.2

Gastrointestinal diseases

Botulism

0.0

0.1

0.0

0.0

0.0

0.0

0.1

0.0

0.0

Campylobacteriosis

117.7

NN

83.6

82.2

95.6

159.8

102.0

72.8

92.9

Cryptosporidiosis

21.3

33.1

46.3

25.6

9.2

33.7

41.9

25.0

31.1

Haemolytic uraemic syndrome

0.0

0.2

0.0

0.1

0.0

0.0

0.0

0.0

0.1

Hepatitis A

1.1

1.7

0.0

0.6

1.5

0.0

1.3

0.9

1.2

Hepatitis E

0.0

0.4

0.0

0.0

0.0

0.0

0.3

0.5

0.3

Listeriosis

1.1

0.6

1.8

0.5

0.0

0.8

0.4

0.5

0.5

STEC, VTEC ||

1.1

0.6

0.0

0.6

5.4

0.0

0.3

0.0

0.8

Salmonellosis

80.7

63.5

211.8

97.7

62.4

90.8

73.6

63.2

75.2

Shigellosis

4.5

2.2

49.8

2.1

1.5

0.8

1.8

3.1

2.6

Typhoid Fever

1.1

1.3

0.0

1.1

1.2

0.0

1.8

0.5

1.2

Quarantinable diseases

Cholera

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Highly Pathogenic Avian Influenza in Humans

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Plague

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Rabies

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Severe Acute Respiratory Syndrome

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Smallpox

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Viral haemorrhagic fever

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Yellow fever

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Sexually transmissible infections

Chlamydial infection ¶**

363.3

300.1

1,151.5

430.3

339.1

330.1

364.1

520.2

378.4

Donovanosis

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Gonococcal infection

43.7

61.8

774.2

62.8

29.0

9.6

57.5

92.1

67.5

Syphilis - congenital

0.0

0.0

0.0

0.1

0.0

0.0

0.0

0.0

0.0

Syphilis < 2 years

4.5

9.2

7.1

6.8

2.0

4.8

7.2

4.5

7.0

Syphilis > 2 years or unspecified duration

2.2

4.3

26.7

7.4

7.7

4.0

13.3

6.1

7.8

Vaccine preventable diseases

Diphtheria

0.0

0.0

0.0

0.0

0.2

0.0

0.0

0.0

0.0

Haemophilus influenzae type b

0.0

0.1

0.0

0.1

0.0

0.0

0.0

0.0

0.1

Influenza (laboratory confirmed)

49.3

22.3

234.9

71.2

78.7

6.4

23.8

50.4

41.9

Measles

0.0

0.1

0.0

0.1

0.5

0.0

0.2

0.5

0.2

Mumps

0.0

1.3

0.0

0.7

0.2

1.6

0.7

4.9

1.3

Pertussis

53.8

35.7

67.6

108.9

38.6

259.4

56.6

69.6

65.1

Pneumococcal disease (invasive)

2.2

3.6

26.7

3.4

4.0

4.8

3.7

3.7

3.9

Poliomyelitis

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Rubella

0.0

0.1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Rubella Congenital

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Tetanus

0.0

0.1

0.0

0.0

0.2

0.0

0.0

0.2

0.1

Vaccine preventable diseases, cont’d

Varicella zoster (Chickenpox)

7.8

NN

69.4

4.3

22.3

1.6

9.8

8.6

9.9

Varicella zoster (Shingles)

5.6

NN

78.3

1.2

114.6

56.2

21.0

51.7

31.6

Varicella zoster (Unspecified)

34.8

NN

1.8

106.3

8.9

16.1

48.7

54.6

60.4

Vectorborne diseases

Arbovirus infection (NEC)

0.0

0.0

1.8

0.4

0.0

0.0

0.0

0.0

0.1

Barmah Forest virus infection

3.4

7.5

231.4

59.2

8.2

0.0

1.8

77.3

25.9

Dengue virus infection

3.4

3.3

32.0

14.8

4.2

2.4

7.0

21.3

8.8

Japanese encephalitis virus infection

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Kunjin virus infection

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Malaria

9.0

1.3

12.5

3.9

0.5

1.6

1.5

5.1

2.5

Murray Valley encephalitis virus infection

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Ross River virus infection

1.1

6.5

124.6

44.3

12.6

3.2

4.2

95.3

24.3

Zoonoses

Anthrax

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Australian bat lyssavirus

0.0

0.0

0.0

0.1

0.0

0.0

0.0

0.0

0.0

Brucellosis

0.0

0.0

0.0

0.4

0.0

0.0

0.0

0.0

0.1

Leptospirosis

0.0

0.1

0.0

1.1

0.0

0.0

0.0

0.0

0.3

Lyssavirus (NEC)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Ornithosis

0.0

0.1

0.0

0.0

0.0

0.0

0.2

0.5

0.1

Q fever

0.0

1.6

0.0

4.2

1.7

0.0

0.7

0.3

1.7

Tularaemia

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Other bacterial infections

Legionellosis

0.0

1.1

0.0

1.8

3.5

1.6

1.7

2.8

1.7

Leprosy

0.0

0.1

0.0

0.0

0.0

0.0

0.1

0.0

0.0

Meningococcal disease (invasive) ††

1.1

0.4

0.0

0.9

1.5

0.8

0.5

1.0

0.7

Tuberculosis

5.6

4.8

23.1

4.7

4.7

1.6

6.8

5.8

5.5

* Date of diagnosis is the date of symptom onset, or if this is not available, the earliest of the specimen collection date, the notification date (when the health professional signed the form or laboratory issued the results), or the notification receive date (when notification of the disease was received by the health authority). Hepatitis B and C and tuberculosis were analysed by date of notification.
† Newly-acquired hepatitis includes cases where the infection was determined to have been acquired within 24 months prior to diagnosis.
‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined.
§ Infections with Shiga-like toxin (verotoxin) producing Escherichia coli.
|| In the national case definitions for chlamydial, gonnoccocal and syphilis infection, the mode of transmission cannot be inferred from the site of infection. Transmission (especially in children) may be by a non-sexual mode.
¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for in South Australia, where only genital tract specimens are reported, and the Northern Territory and Western Australia where ocular specimens are excluded, and Western Australia also excludes perinatal infection.
** Only invasive meningococcal disease is nationally notifiable, but New South Wales, the Australia Capital Territory and South Australia also report conjunctival cases.
NN Not notifiable
NEC Not elsewhere classified

Top of page

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

This issue - Vol 37 No 2, June 2013

Communicable Diseases Intelligence